{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:49:39Z","timestamp":1788778179944,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["350006"],"award-info":[{"award-number":["350006"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Conventional chemotherapeutic regimens are unable to prevent metastasis of non-small cell lung carcinoma (NSCLC) thereby leaving cancer incurable. Cancer stem cells (CSCs) are considered to be the origin of this therapeutic limitation. In the present study we report that the migration potential of NSCLCs is linked to its CSC content. While cisplatin alone fails to inhibit the migration of CSC-enriched NSCLC spheroids, in a combination with non-steroidal anti inflammatory drug (NSAID) aspirin retards the same. A search for the underlying mechanism revealed that aspirin pre-treatment abrogates p300 binding both at TATA-box and initiator (INR) regions of mTOR promoter of CSCs, thereby impeding RNA polymerase II binding at those sites and repressing mTOR gene transcription. As a consequence of mTOR down-regulation, Akt is deactivated\n                    <jats:italic>via<\/jats:italic>\n                    dephosphorylation at Ser\n                    <jats:sup>473<\/jats:sup>\n                    residue thereby activating Gsk3\u03b2 that in turn causes destabilization of Snail and \u03b2-catenin, thus reverting epithelial to mesenchymal transition (EMT). However, alone aspirin fails to hinder migration since it does not inhibit the Integrin\/Fak pathway, which is highly activated in NSCLC stem cells. On the other hand, in aspirin pre-treated CSCs, cisplatin stalls migration by hindering the integrin pathway. These results signify the efficacy of aspirin in sensitizing NSCLC stem cells towards the anti-migration effect of cisplatin. Cumulatively, our findings raise the possibility that aspirin might emerge as a promising drug in combinatorial therapy with the existing chemotherapeutic agents that fail to impede migration of NSCLC stem cells otherwise. This may consequently lead to the advancement of remedial outcome for the metastatic NSCLCs.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-53134-0","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T06:03:48Z","timestamp":1573797828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration"],"prefix":"10.1038","volume":"9","author":[{"given":"Poulami","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debomita","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghya","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"53134_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics. CA Cancer J Clin 67, 7\u201330 (2017).","journal-title":"CA Cancer J Clin"},{"key":"53134_CR2","doi-asserted-by":"publisher","first-page":"1234850","DOI":"10.1126\/science.1234850","volume":"342","author":"MA Nieto","year":"2013","unstructured":"Nieto, M. A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342, 1234850 (2013).","journal-title":"Science"},{"key":"53134_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328\u2013337 (2013).","journal-title":"Nature"},{"key":"53134_CR4","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-15-1360","volume":"76","author":"S Saha","year":"2016","unstructured":"Saha, S. et al. Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NF\u03baB-IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells. Cancer Res 76, 2000\u20132012 (2016).","journal-title":"Cancer Res"},{"key":"53134_CR5","doi-asserted-by":"publisher","first-page":"24553","DOI":"10.1074\/jbc.M110.202341","volume":"286","author":"SF Moore","year":"2011","unstructured":"Moore, S. F., Hunter, R. W. & Hers, I. mTORC2proteincomplex-mediatedAkt(ProteinKinaseB) Serine 473 Phosphorylation is not required for Akt1 activity in human platelets [corrected]. J Biol Chem 286, 24553\u201324560 (2011).","journal-title":"J Biol Chem"},{"key":"53134_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.yjmcc.2015.10.015","volume":"89","author":"J Noh","year":"2015","unstructured":"Noh, J. et al. Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations. J Mol Cell Cardiol 89, 297\u2013305 (2015).","journal-title":"J Mol Cell Cardiol"},{"key":"53134_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-172","volume":"12","author":"Y Tu","year":"2013","unstructured":"Tu, Y. et al. DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival. Mol Cancer 12, 172 (2013).","journal-title":"Mol Cancer"},{"key":"53134_CR8","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/stem.521","volume":"28","author":"J Sunayama","year":"2011","unstructured":"Sunayama, J. et al. Crosstalk between the PI3K\/mTOR and MEK\/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells 28, 1930\u20131939 (2011).","journal-title":"Stem Cells"},{"key":"53134_CR9","first-page":"59","volume":"37","author":"CH Zheng","year":"2018","unstructured":"Zheng, C. H. et al. CDK5RAP3 suppresses Wnt\/\u03b2- catenin signaling by inhibiting AKT phosphorylation in gastric cancer. J ExpClin Cancer Res 37, 59 (2018).","journal-title":"J ExpClin Cancer Res"},{"key":"53134_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2045-3701-4-13","volume":"4","author":"C Gao","year":"2014","unstructured":"Gao, C., Xiao, G. & Hu, J. Regulation of Wnt\/\u03b2-catenin signaling by posttranslationalmodifications. Cell Biosci 4, 13 (2014).","journal-title":"Cell Biosci"},{"key":"53134_CR11","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/j.ejca.2013.03.014","volume":"49","author":"H Zheng","year":"2013","unstructured":"Zheng, H. et al. Glycogen synthase kinase-3 beta regulates Snail and \u03b2-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer. Eur J Cancer 49, 2734\u20132746 (2013).","journal-title":"Eur J Cancer"},{"key":"53134_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.331","volume":"8","author":"J Li","year":"2017","unstructured":"Li, J. et al. MET\/SMAD3\/SNAIL circuit mediated by miR- 323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer. Cell Death Dis 8, e3010 (2017).","journal-title":"Cell Death Dis"},{"key":"53134_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2078-7","volume":"16","author":"P Khan","year":"2016","unstructured":"Khan, P. et al. Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K- ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug. BMC Cancer 16, 39 (2016).","journal-title":"BMC Cancer"},{"key":"53134_CR14","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.18632\/oncotarget.23616","volume":"9","author":"YW Sun","year":"2017","unstructured":"Sun, Y. W., Xu, J., Zhou, J. & Liu, W. J. Targeted drugs for systemic therapy of lung cancer with brain metastases. Oncotarget 9, 5459\u20135472 (2017).","journal-title":"Oncotarget"},{"key":"53134_CR15","first-page":"1108","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin \u03b25-mediated glycolysis. Am J Cancer Res 6, 1108\u20131117 (2016).","journal-title":"Am J Cancer Res"},{"key":"53134_CR16","first-page":"23","volume":"37","author":"J Luo","year":"2018","unstructured":"Luo, J. et al. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3K\/AKT signaling. J ExpClin Cancer Res 37, 23 (2018).","journal-title":"J ExpClin Cancer Res"},{"key":"53134_CR17","first-page":"1207","volume":"2","author":"S Nakahara","year":"2003","unstructured":"Nakahara, S. et al. Involvement of oligosaccharide changes in alpha5beta1 integrin in a cisplatin- resistant human squamous cell carcinoma cell line. Mol Cancer Ther 2, 1207\u20131214 (2003).","journal-title":"Mol Cancer Ther"},{"key":"53134_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"M Canel","year":"2013","unstructured":"Canel, M., Serrels, A., Frame, M. C. & Brunton, V. G. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 126, 393\u2013401 (2013).","journal-title":"J Cell Sci"},{"key":"53134_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3695-5","volume":"17","author":"K Gohr","year":"2017","unstructured":"Gohr, K., Hamacher, A., Engelke, L. H. & Kassack, M. U. Inhibition of PI3K\/Akt\/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38. BMC Cancer 17, 711 (2017).","journal-title":"BMC Cancer"},{"key":"53134_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.534","volume":"5","author":"S Mohanty","year":"2014","unstructured":"Mohanty, S. et al. ROS-PIAS\u03b3 cross talk channelizes ATM signaling from resistance to apoptosis during chemosensitization of resistant tumors. Cell Death Dis 5, e1021 (2014).","journal-title":"Cell Death Dis"},{"key":"53134_CR21","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1158\/1535-7163.MCT-15-0114-T","volume":"14","author":"T Liu","year":"2015","unstructured":"Liu, T. et al. USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry. Mol Cancer Ther 14, 2121\u20132131 (2015).","journal-title":"Mol Cancer Ther"},{"key":"53134_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/scrt506","volume":"5","author":"S Mukherjee","year":"2014","unstructured":"Mukherjee, S. et al. Curcumin inhibits breast cancer stem cell migration by amplifying the E- cadherin\/\u03b2-catenin negative feedback loop. Stem Cell Res Ther 5, 116 (2014).","journal-title":"Stem Cell Res Ther"},{"key":"53134_CR23","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1038\/onc.2016.26","volume":"35","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee, S. et al. Non- migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells. Oncogene 35, 4937\u20134948 (2016).","journal-title":"Oncogene"},{"key":"53134_CR24","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.celrep.2016.02.034","volume":"14","author":"E Beerling","year":"2016","unstructured":"Beerling, E. et al. Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity. Cell Rep 14, 2281\u20132288 (2016).","journal-title":"Cell Rep"},{"key":"53134_CR25","doi-asserted-by":"publisher","first-page":"16105","DOI":"10.1038\/cddiscovery.2016.105","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang, P., Wan, W., Xiong, S. L., Feng, H. & Wu, N. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov 3, 16105 (2017).","journal-title":"Cell Death Discov"},{"key":"53134_CR26","first-page":"7513","volume":"14","author":"J Zuo","year":"2017","unstructured":"Zuo, J. et al. Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP 9. Oncol Lett 14, 7513\u20137521 (2017).","journal-title":"Oncol Lett"},{"key":"53134_CR27","first-page":"5163","volume":"8","author":"JX Liang","year":"2015","unstructured":"Liang, J. X., Gao, W., Liang, Y. & Zhou, X. M. Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysis. Int J ClinExp Med 8, 5163\u20135174 (2015).","journal-title":"Int J ClinExp Med"},{"key":"53134_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc3597","volume":"13","author":"B Beck","year":"2013","unstructured":"Beck, B. & Blanpain, C. Unravelling cancer stem cell potential. Nat Rev Cancer 13, 727\u2013738 (2013).","journal-title":"Nat Rev Cancer"},{"key":"53134_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3892\/ijo.2016.3812","volume":"50","author":"Z Tu","year":"2017","unstructured":"Tu, Z. et al. CXCR4isinvolvedinCD133-inducedEMTinnon-smallcelllungcancer. Int J Oncol 50, 505\u2013514 (2017).","journal-title":"Int J Oncol"},{"key":"53134_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.canlet.2017.10.018","volume":"412","author":"RM Liu","year":"2018","unstructured":"Liu, R. M. et al. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3\u03b2. Cancer Lett 412, 289\u2013296 (2018).","journal-title":"Cancer Lett"},{"key":"53134_CR31","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/stem.1669","volume":"32","author":"C Segrelles","year":"2014","unstructured":"Segrelles, C. et al. Akt signaling leads to stem cell activation and promotes tumor development in epidermis. Stem Cells 32, 1917\u20131928 (2014).","journal-title":"Stem Cells"},{"key":"53134_CR32","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.3748\/wjg.v20.i29.10038","volume":"20","author":"M Spampatti","year":"2014","unstructured":"Spampatti, M. et al. Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells. World J Gastroenterol 20, 10038\u201310049 (2014).","journal-title":"World J Gastroenterol"},{"key":"53134_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep13390","volume":"5","author":"W Yue","year":"2015","unstructured":"Yue, W. et al. Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. Sci Rep 5, 13390 (2015).","journal-title":"Sci Rep"},{"key":"53134_CR34","doi-asserted-by":"publisher","first-page":"42232","DOI":"10.1074\/jbc.M111.262295","volume":"286","author":"GS Sen","year":"2011","unstructured":"Sen, G. S. et al. Curcumin enhances the efficacy of chemotherapy by tailoring p65NF\u03baB\u2013p300 cross- talk in favor of p53\u2013p300 in breast cancer. J Biol Chem 286, 42232\u201342247 (2011).","journal-title":"J Biol Chem"},{"key":"53134_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep13249","volume":"5","author":"Y Yoshino","year":"2015","unstructured":"Yoshino, Y. & Ishioka, C. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Sci Rep 5, 13249 (2015).","journal-title":"Sci Rep"},{"key":"53134_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejphar.2008.06.028","volume":"591","author":"M Wangpaichitr","year":"2008","unstructured":"Wangpaichitr, M. et al. Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins. Eur J Pharmacol 591, 124\u2013127 (2008).","journal-title":"Eur J Pharmacol"},{"key":"53134_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.lungcan.2010.08.022","volume":"71","author":"A Chang","year":"2011","unstructured":"Chang, A. Chemotherapy, chemoresistance and the changing treatment landscape forNSCLC. Lung Cancer. 71, 3\u201310 (2011).","journal-title":"Lung Cancer."},{"key":"53134_CR38","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1158\/1535-7163.MCT-12-0448","volume":"11","author":"L Wang","year":"2012","unstructured":"Wang, L., Mosel, A. J., Oakley, G. G. & Peng, A. Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer. Mol Cancer Ther 11, 2401\u20132409 (2012).","journal-title":"Mol Cancer Ther"},{"key":"53134_CR39","doi-asserted-by":"publisher","first-page":"e1824","DOI":"10.1038\/cddis.2015.195","volume":"6","author":"SQ Liang","year":"2015","unstructured":"Liang, S. Q. et al. Blocking the epithelial-to- mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer. Cell Death & Disease 6, e1824 (2015).","journal-title":"Cell Death & Disease"},{"key":"53134_CR40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ijc.23086","volume":"122","author":"M Fraser","year":"2008","unstructured":"Fraser, M., Bai, T. & Tsang, B. K. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Int J Cancer 122, 534\u2013546 (2008).","journal-title":"Int J Cancer"},{"key":"53134_CR41","doi-asserted-by":"crossref","first-page":"108726","DOI":"10.18632\/oncotarget.21711","volume":"8","author":"L Jiang","year":"2017","unstructured":"Jiang, L. et al. TrkB promotes laryngeal cancer metastasis via activation PI3K\/AKTpathway. Oncotarget 8, 108726\u2013108737 (2017).","journal-title":"Oncotarget"},{"key":"53134_CR42","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.4161\/cc.26173","volume":"12","author":"B Corominas-Faja","year":"2013","unstructured":"Corominas-Faja, B. et al. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway. Cell Cycle 12, 3109\u20133124 (2013).","journal-title":"Cell Cycle"},{"issue":"12","key":"53134_CR43","doi-asserted-by":"publisher","first-page":"e28405","DOI":"10.1371\/journal.pone.0028405","volume":"6","author":"Z Yang","year":"2011","unstructured":"Yang, Z. et al. Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations. PLoS One 6(12), e28405 (2011).","journal-title":"PLoS One"},{"key":"53134_CR44","doi-asserted-by":"publisher","first-page":"16158","DOI":"10.1073\/pnas.0702596104","volume":"104","author":"J Zhou","year":"2007","unstructured":"Zhou, J. et al. Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 104, 16158\u201316163 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53134_CR45","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/onc.2016.427","volume":"36","author":"F Mateo","year":"2017","unstructured":"Mateo, F. et al. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. Oncogene 36, 2737\u20132749 (2017).","journal-title":"Oncogene"},{"key":"53134_CR46","doi-asserted-by":"publisher","first-page":"39450","DOI":"10.1074\/jbc.M111.265330","volume":"286","author":"N Case","year":"2011","unstructured":"Case, N. et al. Mechanical regulation of glycogen synthase kinase 3\u03b2 (GSK3\u03b2) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein. J Biol Chem 286, 39450\u201339456 (2011).","journal-title":"J Biol Chem"},{"issue":"3","key":"53134_CR47","doi-asserted-by":"publisher","first-page":"e91231","DOI":"10.1371\/journal.pone.0091231","volume":"9","author":"J Zeng","year":"2014","unstructured":"Zeng, J. et al. GSK3\u03b2 Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells. PLoS One 9(3), e91231 (2014).","journal-title":"PLoS One"},{"key":"53134_CR48","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1159\/000485405","volume":"44","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer. Cell Physiol Biochem. 44, 1051\u20131063 (2017).","journal-title":"Cell Physiol Biochem."},{"key":"53134_CR49","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.18632\/oncotarget.10169","volume":"8","author":"R Huang","year":"2017","unstructured":"Huang, R. et al. Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget. 8, 35351\u201335367 (2017).","journal-title":"Oncotarget."},{"key":"53134_CR50","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.18632\/oncotarget.3171","volume":"6","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Oncotarget. 6, 9999\u201310015 (2015).","journal-title":"Oncotarget."},{"key":"53134_CR51","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1172\/JCI121985","volume":"130","author":"S Lucotti","year":"2019","unstructured":"Lucotti, S. et al. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2. J Clin Invest. 130, 1845\u20131862 (2019).","journal-title":"J Clin Invest."},{"key":"53134_CR52","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-16-1741","volume":"77","author":"L Kotelevets","year":"2017","unstructured":"Kotelevets, L. et al. A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer. Cancer Res. 77, 2964\u20132975 (2017).","journal-title":"Cancer Res."},{"key":"53134_CR53","doi-asserted-by":"publisher","first-page":"16654","DOI":"10.1073\/pnas.1205822109","volume":"109","author":"ZQ Wu","year":"2012","unstructured":"Wu, Z. Q. et al. Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA 109, 16654\u201316659 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53134_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep12363","volume":"5","author":"D Jiehui","year":"2015","unstructured":"Jiehui, D. Rap2B promotes proliferation, migration, and invasion of human breast cancer through calcium-related ERK1\/2 signaling pathway. Sci Rep. 5, 12363 (2015).","journal-title":"Sci Rep."},{"key":"53134_CR55","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.trsl.2014.10.011","volume":"165","author":"S Saha","year":"2015","unstructured":"Saha, S. et al. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin. Transl Res 165, 558\u2013577 (2015).","journal-title":"Transl Res"},{"key":"53134_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1656-4","volume":"10","author":"EL Mazzoldi","year":"2019","unstructured":"Mazzoldi, E. L. et al. A juxtacrine\/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer. Cell Death Dis. 10, 412 (2019).","journal-title":"Cell Death Dis."},{"key":"53134_CR57","doi-asserted-by":"publisher","first-page":"29074","DOI":"10.1074\/jbc.M114.564872","volume":"289","author":"S Chakraborty","year":"2014","unstructured":"Chakraborty, S. et al. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6transcriptio n through alteration of chromatin histone deacetylation. J Biol Chem 289, 29074\u201329085 (2014).","journal-title":"J Biol Chem"},{"key":"53134_CR58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.febslet.2013.11.040","volume":"588","author":"S Chakraborty","year":"2014","unstructured":"Chakraborty, S. et al. Restoration of p53\/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells. FEBS Lett 588, 549\u2013559 (2014).","journal-title":"FEBS Lett"},{"key":"53134_CR59","doi-asserted-by":"publisher","first-page":"25431","DOI":"10.1074\/jbc.M113.527267","volume":"289","author":"A Adhikary","year":"2014","unstructured":"Adhikary, A. et al. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold\/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells. J Biol Chem. 289, 25431\u201325444 (2014).","journal-title":"J Biol Chem."},{"key":"53134_CR60","doi-asserted-by":"crossref","unstructured":"Alan Serrels, et al. The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells. International Journal of Cancer 131 (2):287\u2013297 (2012).","DOI":"10.1002\/ijc.26351"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53134-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53134-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53134-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:58:04Z","timestamp":1671274684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53134-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53134"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53134-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16913"}}